The hypothalamus is a region of the diencephalon with particularly complex patterning. Sonic hedgehog (Shh), encoding a protein with key developmental roles, shows a peculiar and dynamic diencephalic expression pattern. Here, we use transgenic strategies and in vitro experiments to test the hypothesis that Shh expressed in the diencephalic neuroepithelium (neural Shh) coordinates tissue growth and patterning in the hypothalamus. Our results show that neural Shh coordinates anteroposterior and dorsoventral patterning in the hypothalamus and in the diencephalon-telencephalon junction. Neural Shh also coordinates mediolateral hypothalamic patterning, since it is necessary for the lateral hypothalamus to attain proper size and is required for the specification of hypocretin/orexin cells. Finally, neural Shh is necessary to maintain expression of differentiation markers including survival factor Foxb1.
Introduction
The hypothalamus is a ventral forebrain region regulating homeostasis and reproduction. Alterations of hypothalamic development can result in endocrine and metabolic disease (Michaud, 2001; Caqueret et al., 2005) . Hypothalamic patterning, however, is not well understood. The embryonic hypothalamus forms the rostral-ventral part of the diencephalon. This is a complex region that, together with the caudal-dorsal diencephalon (prethalamic region), forms the diencephalon-telencephalon junction (DTJ). The adult hypothalamus consists of medial and lateral zones. The medial hypothalamus is a series of neuronal aggregates arranged rostrocaudally into four areas called preoptic, anterior, tuberal, and mammillary (MAM), each of them expressing specific markers. The lateral hypothalamus regulates ingestive, aggressive, and reproductive behaviors; without recognizable neuronal nuclei, it is anatomically and functionally very intricate (Simerly, 2004) , and information about its specification and patterning is scarce. Specific lateral hypothalamus subpopulations expressing melanin-concentrating hormone (Pmch) and hypocretin (Hcrt) are essential for the coordination of sleep-wake cycles and feeding behavior (Burdakov et al., 2005) .
Ventral patterning of the nervous system is controlled by signaling protein Shh, secreted by non-neural tissues like the prechordal plate and notochord (non-neural Shh) (Ericson et al., 1997; Gunhaga et al., 2000; Ingham and McMahon, 2001 ). However, Shh is also expressed by the ventral midline of the neural tube (neural Shh). Neural Shh is essential for the coordination of tissue growth and pattern in the midbrain-hindbrain junction and cerebellum (Blaess et al., 2006 (Blaess et al., , 2008 . In the diencephalic neuroepithelium, Shh shows an intriguing and dynamic pattern of expression with domains in the caudal-dorsal diencephalon [zona limitans interthalamica (ZLI)] and the rostral-ventral diencephalon (hypothalamic domain), which seem strategically situated to influence the formation of the DTJ. In the caudal diencephalon, neural Shh from the ZLI specifies the prethalamus (PTh) (Hashimoto-Torii et al., 2003; Kiecker and Lumsden, 2004; Vieira et al., 2005; Hirata et al., 2006; Scholpp et al., 2006; Guinazu et al., 2007) and promotes growth and differentiation of specific subdivisions of the thalamus (Szabó et al., 2009) . The role of neural Shh in the rostral diencephalon (hypothalamus) and DTJ, however, is only starting to be analyzed.
We approached the role of neural Shh in hypothalamic development through analysis of a conditional mouse mutant as well as experiments in vitro. Our results show that neural Shh coordinates tissue growth with anteroposterior (AP) and dorsoventral (DV) patterning in the diencephalon and is essential for the formation of the DTJ. In the lateral hypothalamus, neural Shh is required for proper size of this zone and for the specification of hypocretin/orexin cells. Finally, neural Shh is necessary to maintain expression of differentiation markers including survival factor Foxb1.
Materials and Methods

Mutant mouse lines
Animals were treated in ways that minimize suffering and under authorization Az 32.22/Vo from the "Ordnungsamt der Stadt Göttingen," according to the German Law of Animal Protection.
Foxb1-Cre line. This line expresses Cre recombinase in the mouse diencephalon (Zhao et al., 2007 (Zhao et al., , 2008 , and it is a knock-in-knock-out generating Foxb1 heterozygous animals. These heterozygotes do not show haploinsufficiency and can be considered identical with wild type (WT) (Dou et Foxb1-Cre/ROSA26R lineage reporter line. In heterozygous Foxb1-Cre embryos carrying ROSA26 (Soriano, 1999) or Z/AP (Lobe et al., 1999) reporter alleles, all cells that express or have expressed Foxb1, and any cells derived from them, permanently produce ␤-galactosidase (ROSA26R) or human placental alkaline phosphatase (hPLAP; Z/AP), labeling the Foxb1 lineage (Zhao et al., 2007) .
Conditional allele of Sonic hedgehog. In this conditional allele, exon 2 of Shh is flanked by loxP sites (Dassule et al., 2000; Lewis et al., 2001) . Exon 2 encodes approximately one-half of the active N-terminal Shh signal, essential for Shh function (Mann and Beachy, 2004 In Shh-c mutants, exon 2 of the Shh locus has been deleted in the entire Foxb1 lineage, including the caudal diencephalon, the posterior ventral hypothalamus, and the diencephalic ventral midline (Zhao et al., 2007 (Zhao et al., , 2008 . In Shh-c mutants, whenever transcription from the Shh locus occurs (in cells of the Foxb1 lineage), the recombined Shh locus produces a truncated, nonfunctional mRNA lacking exon 2. An exon 2 probe exclusively detects the functional Shh mRNA (full length).
Shh full mutants. To generate full Shh mutants (see below) (see Fig.  1 I, J), we crossed the Shh-floxed (Dassule et al., 2000) with a transgenic mouse line carrying Cre under an ubiquitous promoter expressed in embryonic stem cells (Schwenk et al., 1995) , in this way producing full mutant homozygous embryos (CMV-Cre/Shh-floxed).
Transfection constructs and electroporation
To test the lack of function of Shh without exon 2, we prepared constructs expressing exon 2-deleted Shh-IRES-EGFP [green fluorescent protein (GFP)] under the control of CAGGS promoter. We obtained a plasmid containing the full-length Shh cDNA (from imaGenes), clone IRAVp968F10144D, and we cloned this cDNA into pXL172 (CAGGS promoter-multicloning site-IRES-EGFP). Next, we used PCR to synthesize an exon 2-deleted Shh cDNA. In a first PCR step, we used Shh cDNA as template to amplify exon 1 and exon 3 in separate reactions. In each reaction, we used "bridge" primers so that the 3Ј primer for exon 1 contained 24 nt of the 5Ј end of exon 3, and vice versa. We used the product of this amplification as template in a second PCR step, which produced a final continuous exon 1-exon 3 fragment (i.e., exon 2-deleted), which was also cloned into pXL172. The constructs were confirmed by sequencing.
Embryonic day 10.5 (E10.5) mouse brains were harvested, injected with 2 g/l DNA, and then electroporated with a CUY21EDIT Nepagene square wave electroporator (Nepa Gene) and the "tweezer electrodes" (22 V; 50 ms Pon, 950 ms Poff; three pulses). The brains were then cut open and cultured for 48 h (see below, Explants), and then GFP expression was analyzed and photographed, and the explants were fixed and treated for whole-mount in situ hybridization (ISH).
ISH and reporter detection
Templates were PCR-amplified (primer sequence available on request) from cDNA (from total RNA from newborn mouse brain plus E10.5-E11.5 embryos). Probes were synthesized using the Roche RNA transcription kit (DIG RNA or Fluorescein RNA Labeling Mix). ISH on whole mount or on cryostat sections has been described often. For double whole-mount ISH, probes were labeled with either digoxygenin or fluorescein. Antibodies were as follows: anti-fluorescein-alkaline phosphatase (Fab fragment) (1:5000) and anti-digoxigenin-alkaline phosphatase (Fab fragment) (1:5000) (both from Roche). Color substrates were as follows: BM Purple, Fast Red, or INT (2-[4-iodophenyl]-3-[4-nitrophenyl]-5-phenyltetrazolium chloride)/BCIP (5-bromo-4-chloro-3-indolyl phosphate) (Roche).
Staining for alkaline phosphatase and for ␤-galactosidase activity were performed as described previously (Koenen et al., 1982; Lobe et al., 1999) .
5-Bromo-2Ј-deoxyuridine labeling
Pregnant mice were intraperitoneally injected with 5-bromo-2Ј-deoxyuridine (BrdU) (RPN201; GE Healthcare) (50 g/g of body weight) either at E10.5 or at E12.5, and the embryos were collected 1 h (E10.5) or 3 h (E12.5) later. We used anti-BrdU antibody M0744 (1:100) (Dako) on 20 m cryosections after epitope retrieval (2 M HCl for 30 min at 37°C), with nuclear marker 4Ј,6-diamidino-2-phenylindole dihydrochloride (DAPI) (Invitrogen) as a counterstain. We examined and photographed the sections under confocal microscopy and counted BrdUlabeled and -unlabeled cells in the neuroepithelium on two histological sections (per level) at one rostral (anterior hypothalamic) and one caudal (MAM) level in three animals per age and genotype (wild type and Shhc). Then we calculated the labeling index (BrdU-labeled cells as percentage of total cells) (Takahashi et al., 1993; Warren et al., 1999; Ishibashi and McMahon, 2002) .
Apoptosis detection
We selected cryostat sections of E10.5 and E12.5 brains at two hypothalamic rostrocaudal levels (anterior hypothalamic region and MAM) in three individuals per genotype and pretreated them with 4% paraformaldehyde (20 min) and proteinase K (1.5 g/ml; 5 min) at room temperature and then labeled the apoptotic cells with the ApopTag terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling kit (Millipore) according to the instructions of the manufacturer. We counted absolute number of apoptotic cells per histological section of the hypothalamus (both sides) under high magnification with DAPI as counterstain.
Statistical analysis
ANOVA was performed with Prism software (GraphPad Software).
Explants
E9.5 wild-type mouse brains were cut open along the ventral midline, flattened (neuroepithelial side down) on Millicell-CM membranes (Millipore), and cultured under standard conditions in Neurobasal/glutamine (2 mM)/B-27 (Invitrogen). The following experimental reagents were added: Wnt pathway inhibitor 4-(4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)-5-pyridin-2-yl-1 H-imidazol-2-yl)benzamide (D4476) (Rena et al., 2004; Bryja et al., 2007) (50 M in DMSO; Calbiochem), Shh pathway inhibitor cyclopamine (15 M in DMSO; Sigma-Aldrich), and Wnt pathway activator LiCl (Klein and Melton, 1996) (10 mM; Sigma-Aldrich). Control experiments were performed in parallel with equal DMSO (NaCl to control for LiCl) concentrations. None of the reagents increased cell death ("Live/Dead" Viability/Cytotoxicity kit; Invitrogen) (data not shown). After 48 h, explants were fixed (4% paraformaldehyde) and processed for ISH. The Foxb1-expressing area of MAM neuroepithelium was measured on photographs with the help of CellF 2.6 software (Olympus Soft Imaging Solutions). (Dassule et al., 2000; Lewis et al., 2001; Machold et al., 2003; Komada et al., 2008) . On Cre-mediated recombination, the floxed Shh loses exon 2 (Dassule et al., 2000; Lewis et al., 2001) Roelink et al., 1995) . However, we wanted to ascertain that this was also the case in the forebrain neuroepithelium. E10.5 explants transfected with a construct expressing full-length Shh expressed ectopic Ptch1 (diagnostic of Shh pathway activation) (for review, see Lewis et al., 2001) , whereas transfection of Shh constructs in which exon 2 had been deleted did not have any effect (Fig. 1 A-E) .
Results
Foxb1-driven
To analyze our mutants, we needed to know whether and when the mutant neural plate was able to express Shh. At E8.0, Foxb1 was expressed in the ventral midline of the wild-type anterior neural plate (Fig. 1 F) (Zhao et al., 2007) , whereas Shh was expressed in the prechordal mesendoderm but not yet in the neural plate of wild type or mutant (Fig. 1G,H ) . Foxb1 was expressed in the neural plate of a Shh Ϫ / Ϫ embryo (full Shh knockout mutant), indicating that Shh is not required for initiation of Foxb1 expression ( Fig. 1 I, J ) .
At E8.5, both Foxb1 and Shh were expressed in the wild-type ventral neural plate ( Fig. 1 K, L) . In the mutant, the Shh locus was active as revealed by ISH with a "long probe" detecting any Shh transcripts (i.e., wild-type Shh mRNA as well as truncated Shh mRNA, the product of a Cre-recombined Shh locus) ( Fig. 1 M) , but it produced nonfunctional Shh mRNA in the neural plate, as shown by an exon 2 probe, which detects only the product of the wild-type Shh locus (non-Cre-recombined) (see Materials and Methods) ( Fig. 1 N) . At the 12-14 somite stage, Foxb1 and Shh were expressed in wild-type ventral diencephalon with a rostral limit at the optic sulcus ( Fig. 1O ,P, arrowhead) Zhao et al., 2007) . In the mutant, the Shh locus was active in appropriate domains (Fig. 1Q ), but full-length, functional Shh transcripts were limited to the ventral caudal diencephalon ( Fig. 1 R, arrow) , not rostral diencephalon (hypothalamus) ( Fig. 1 R, arrowhead) .
These results indicated complete elimination of functional Shh mRNA in the Shh-c hypothalamus from E8.5 on.
Activation of Shh expression in the basal plate depends on neural Shh
Since diencephalic Foxb1 expression is mostly transient (Zhao et al., 2007 (Zhao et al., , 2008 , we used a lineage reporter mouse line to identify the regions in which a phenotype can be expected. In these embryos, cells that have expressed Foxb1, as well as cells derived from them, express ␤-galactosidase permanently, allowing for the identification of the regions in which Foxb1-driven Cre recombination has taken place (see Materials and Methods).
At 21-24 somites, Foxb1-lineage cells were found in the ventral part of rostral and caudal diencephalon, in the diencephalic ventral midline up to eye levels ( Fig. 1S) , and in the branchial arches (Fig. 1S, arrowheads) . Shh at this age had disappeared from the ventral side (Fig. 1 , compare P, T ) and was expressed in four distinct domains: (1) suboptical, (2) a longitudinal band representing the basal plate (bp) of the rostral diencephalon (Puelles et al., 2004) , (3) a small domain in the MAM, and (4) the incipient ZLI in the caudal diencephalon (Fig. 1T ) . The ventral portion of the tuberal area was devoid of Shh expression at this age ( Fig. 1T, arrowhead) . In Shh-c mutants, Shh transcriptional activation was abolished in the bp and ZLI domains, but maintained in the MAM and suboptical domains (Fig. 1U ). Functional Shh was expressed only in the suboptical domain, with reduced intensity (Fig. 1V ). In the ZLI domain, maintenance of activity in the Shh locus requires Shh (feedback loop) (Kiecker and Lumsden, 2004; Zeltser, 2005) , which explains the lack of a ZLI in this mutant, and possibly also the lack of a bp domain. In contrast, the suboptical domain and the MAM domain can activate Shh expression independently of Shh of neural origin.
The major brain regions can be recognized by expression of specific markers at E12.5 . At this age, the thalamus, the MAM, and scattered cells in prethalamus and hypothalamic floor plate were of Foxb1 lineage (Fig. 1W ), indicating that those regions would not be able to express functional Shh in the mutant. In the wild-type embryo at this age, a new Shh domain was present [medial ganglionic eminence (MGE)] and the domains detected earlier were fully developed (Fig. 1 X) . The MAM showed an Emx2-expressing subdomain corresponding to its most prominent neuronal nucleus, the mammillary body (MBO) (Fig. 1 X, inset; supplemental Fig. 1 A, available at www. jneurosci.org as supplemental material) and a Shh-expressing subdomain. The bp domain of Shh expression was still strong in the tuberal area ( Fig. 1 X) . In the Shh-c brain, the bp domain was absent (as well as the ZLI) (Fig. 1Y ) , and most of the remnant Shh transcriptional activity produced inactive Shh transcripts, except for the MGE (Fig. 1Z ).
Early abolition of the Shh pathway in the Shh-c forebrain Non-neural sources of Shh can still activate the Shh pathway in the mutant neuroepithelium. Therefore, we characterized the state of the pathway in Shh-c embryos by detecting expression of Shh receptor Ptch1 and transcription factor gene Gli1, diagnostic markers of Shh pathway activity (for review, see Lewis et al., 2001) . At E8.5, the pathway was active in the mutant ventral midline (Fig. 2 A-D) , probably because of a response to nonneural Shh from the prechordal plate. At 14 somites, Gli1 and Ptch1 expression in the mutant disappeared from the ventral diencephalon ( Fig. 2 E-H ) but was retained in the ventral telencephalon further demonstrating the specific ablation of Shh in the diencephalon (Fig. 2 H) . The loss was maintained at 24 somites ( Fig. 2 I-L) . These results show a shift in the dependence of the wild-type neural plate from non-neural to neural sources of Shh and indicate that, in the Shh-c neural plate, the Shh pathway is rendered inactive very early at diencephalic levels.
Regional hypothalamic patterning in the Shh-c embryo
Shh is essential to specify the hypothalamus (Chiang et al., 1996) . Regional specification of the hypothalamus is defined by Nkx2-1 (Titf1) expression (Kimura et al., 1996; Puelles et al., 2004) . We found Nkx2-1 expression in an appropriate (although reduced in size) region of the Shh-c forebrain at E9.5 (Fig. 3 A, B ) and E11.5 (Fig. 3C,D) , indicating the presence of a ventral forebrain region fated to become hypothalamus.
The major brain regions can be recognized by specific marker expression at E12.5 . To explore the regionalization of the hypothalamus in the absence of neural Shh, we detected expression of Dlx2 (Pierani et al., 2001; Petryniak et al., 2007) and Dbx1 (Lu et al., 1992; Shoji et al., 1996) , transcription factor genes expressed in the presumptive hypothalamus and with important developmental roles. (Nkx2-1 at E12.5 can be seen in Fig. 4 A, B. ) Expression of Dlx2 (Fig. 3 E, F ) and Dbx1 (Fig.  3G,H ) was almost completely abolished in the mutant hypothalamus.
The MAM in the Shh-c embryo Dlx2 expression in the mutant (Fig. 3F ) suggests abolition of the PTh. This could be expected, since neural Shh (from the ZLI) is essential for PTh development, as has been thoroughly documented (see references in Introduction). However, the continuity of dorsal and ventral diencephalon in the absence of a PTh has not been investigated. Rostral to the ZLI, the diencephalon consists of PTh and thalamic eminence [eminentia thalamica (EMT)]. Lhx5 labels specifically the EMT and the MBO, but not the PTh (Bachy et al., 2001) (Fig. 3I ). In the mutant, an abnormal Lhx5 domain encompassed a stripe of dorsal and ventral diencephalon (Fig. 3J ) , as if formed by a fusion between EMT and MAM. Colocalization of this marker with Pitx2, a specific marker of the MAM (Skidmore et al., 2007) , showed that the MAM is not dorsally expanded in the mutant, but the absence of PTh tissue leads to abnormal contiguity of EMT and MAM (Fig. 3 K, L) .
Wnt8b expression labels the MBO in all vertebrates (Cui et al., 1995; Kelly et al., 1995; Lako et al., 1998; Garda et al., 2002; Houart et al., 2002) , as well as the rostral border of the dorsal diencephalon (supplemental Fig. 1 B, available at www.jneurosci. org as supplemental material). In the Shh-c mutant, both domains coalesce (supplemental Fig. 1C , available at www.jneurosci.org as supplemental material) like the Lhx5 domains (Fig. 3J) . Codetection of Wnt8b with Pitx2 (supplemental Fig. 1D ,E, available at www. jneurosci.org as supplemental material) confirmed that both domains become contiguous in the mutant, as opposed to a dorsal expansion of the MAM. The fact that Lhx5 is expressed in a mutant without PTh represents a genetic dissection of the rostral-dorsal diencephalon. We analyzed this by colocalizing EMT marker Tbr1 (Puelles et al., 2000) and PTh marker Arx (Kitamura et al., 1997) , which show contiguous domains in the rostral-dorsal diencephalon (supplemental Fig. 1 F, available at www. jneurosci.org as supplemental material). As expected, Arx was missing in the mutant, but Tbr1 also (supplemental Fig. 1G , available at www.jneurosci.org as supplemental material). [The wild-type expression patterns of Foxg1, Foxd1, Tbr1, and Pitx2 as single markers can be found in supplemental Fig. 1 H-K (available at www.jneurosci.org as supplemental material).]
The apparent fusion of rostral-dorsal diencephalon with the MAM results in an alteration of the DTJ. The expression domains of transcription factor genes Foxd1 and Foxg1 define the DTJ (Hatini et al., 1994; Herrera et al., 2004) (Fig. 3M ) . Codetection of these markers in the mutant was less informative, since Foxd1 failed to be expressed (Fig. 3N) . However, careful examination of the DTJ in our material showed that, in the mutant, it goes all the way to the ventral side, as shown in the diagrams in Figure 3 , O and P.
The DTJ in the Shh-c To examine the DTJ more closely, we sectioned E12.5 wild-type and mutant embryos along the horizontal plane of section (indicated in Fig. 4 A, B , K, L) and labeled them for hypothalamic marker Nkx2-1 as well as MBO marker Emx2 (Fig. 4 A, B, K, L) . Nkx2-1 labeling showed that the mutant tuberal area was much shorter along the anteroposterior axis (Fig. 4 E-H ) and had lost Nkx2-1 expression in a large caudal area (Fig. 4C-J ) .
The most dorsal expression of Nkx2-1 in the hypothalamus (Fig. 4 A, arrow) marked a depression or sulcus in the neural tube (Fig. 4C, arrow) , which could be followed to ventral levels in the wild type (Fig. 4C ,E,G, arrows) and the mutant (Fig. 4D,F,H,J, arrows) .
Emx2 expression labeled the MBO very specifically in the wild type (Fig. 4 K, S; supplemental Fig. 1 A, available at www. jneurosci.org as supplemental material), and in the mutant it was present in an abnormal caudal structure (Fig. 4 L, arrowhead) . Emx2-labeled sections of the mutant showed that the sulcus mentioned above starts at the point (Fig. 4 N, arrow) at which the D) . The arrowheads indicate the foregut. E-H, At 14 -16 somites, both Ptch1 and Gli1 were expressed in the entire ventral neural tube (E, G) but had disappeared from the mutant rostral neural tube (F, H ) except in the sub. I-L, At 21-24 somites, the domain of expression of Ptch1 and Gli1 in wild type (I, K ) showed domains similar to Shh: bp and sub, and an incipient telencephalic domain, MGE (compare with Fig. 1T ), whereas in the mutant both markers were still absent from the forebrain (J, L) except for low-intensity expression of Gli1 in the sub (L).
cortex (telencephalon) meets the diencephalon, in coincidence with the beginning of an Emx2-expressing hypothalamic region which seems an extension of the cortex (Fig. 4 N, arrowhead) . The sulcus could be followed in the ventral direction in the wild type (Fig. 4 M, O ,Q) and mutant (Fig. 4 N 
, P, R, T ).
However, in the Shh-c hypothalamus, Emx2 expression labeled a region flattened rostrocaudally and with a convoluted lumen (Fig. 4 N, P , R, T, arrow and arrowhead) more reminiscent of cortex than hypothalamus.
An Emx1-expressing layered structure in the ventral diencephalon of the Shh-c embryo Emx1 is a very specific cortical marker not expressed in any other structure (Gulisano et al., 1996) and labels the entire cortex of the E12.5 mouse (Fig. 5 A, B) . In the Shh-c mutant, intriguingly, the Emx1-expressing cortex extended toward the midline (Fig. 5C,D , red arrowheads). In coronal sections (Fig. 5E-H ) of wild type and mutant, we could ascertain expression of Emx1 in one layered structure occupying the ventral side of the diencephalon (Fig.  5G,H, red arrowheads) . Detection of Emx1 at E18.5 (Fig. 5 J, K ) confirmed this finding (Fig. 5K, red arrowheads) . Tbr1 is a marker of the pallium (cortex and hippocampus) and thalamic eminence (Bulfone et al., 1995) and it was expressed in a layered structure positioned in the mutant hypothalamus at E18.5 (Fig.  5 L, M ) . Foxg1 (Xuan et al., 1995 ) is a telencephalic marker (Fig.  5N ) also expressed in this structure (Fig. 5O, arrow) .
Cell proliferation and cell death in the Shh-c hypothalamic neuroepithelium at E10.5 and E12.5 Shh promotes proliferation and cell viability in the diencephalic neuroepithelium at E9.0 (Ishibashi and McMahon, 2002) . We wanted to know whether neural Shh controls those cellular processes in the hypothalamus after that age. To address this question, we analyzed Shh-c mutant embryos for proliferation and cell death. We analyzed proliferation by BrdU labeling at E10.5 (1 h survival) and E12.5 (3 h survival). At E10.5, we did not find any difference in labeling index between wild type and mutant (data not shown). At E12.5, however, we found in rostral sections a moderate (ϳ20%) but significant ( p Ͻ 0.001) decrease in proliferation in the mutant (labeling index in rostral hypothalamus: 49.5 Ϯ 0.70 in wild type vs 40 Ϯ 4.20 in the mutant; in caudal hypothalamus: 50 Ϯ 0.5 in wild type vs 51.5 Ϯ 0.70 in the mutant) (data not shown). We did not find changes in cell death in the hypothalamus at E10.5 or E12.5 (data not shown).
The ventral diencephalon of the Shh-c is transversally divided into two parts
Next, we wanted to assess diencephalic differentiation at a later stage, when neurogenesis is over and the mantle layer is differentiated. Since Shh-c mutants do not survive beyond the end of gestation, we analyzed E18.5 brains. Inspection of Nissl-stained sections showed size reduction of the basal ganglia, hypothalamus and thalamic region, and an enlarged third ventricle (Fig.  6 A, B) . As expected from previous results (Fig. 5K ) , a layered structure (Fig. 6 B, asterisk) was positioned medially and ventrally. To identify the major brain regions in the mutant, we used marker genes Gbx2, Nkx2-1, Lhx1, and Calb1. Gbx2, a thalamic transcription factor (Miyashita-Lin et al., 1999), identified a reduced mutant thalamus (Fig. 6C,D) . Expression of Nkx2-1, an essential marker of the early hypothalamus as a region, is restricted during differentiation to specific hypothalamic nuclei including part of the preoptic area and the mamillary body (Price et al., 1992) (Fig. 6 E) . Expression of Nkx2-1 was maintained in the mutant preoptic area (Fig. 6 F) . Immediately caudal to the preoptic area is the anterior hypothalamic area, a prominent nucleus of which is the suprachiasmatic (SCH), specifically expressing transcription factor Lhx1. Lhx1 expression was preserved in the mutant (Fig. 6G,H) . The next rostrocaudal subdivision, the tuberal region, contains the ventromedial nucleus (VMH), specifically expressing Calb1 (Fig. 6I) . In the mutant, the VMH was smaller but expressed the marker (Fig. 6J) . The layered structure was positioned immediately caudal to the VMH in the mutant (Fig. 6J ) but rostral to the MBO (Fig. 6F,H) . This suggested that this structure separated the preoptic, anterior, and tuberal areas from the MAM.
These results are summarized in Figure 6 , K and L. Additional information can be found in supplemental Figure 2 (available at www.jneurosci.org as supplemental material).
Neural Shh is required for the development of the lateral hypothalamus
To explore the mediolateral extension of the mutant hypothalamus we detected expression of arginine vasopressin (Avp), which encodes a hormone specifically expressed in the paraventricular (PVN) and supraoptic (SO) nuclei (Fig. 7A) . In the mutant, the PVN was reduced, Avp neurons were scattered in the mediolateral plane and the SO was absent (Fig. 7B) . However, on sagittal sections labeled with specific marker genes Sim1 (Michaud et al., 1998) and Otp (Acampora et al., 1999 ) (supplemental Fig. 2 E-H , available at www.jneurosci.org as supplemental material), the PVN was not expanded rostrocaudally. Since the hypothalamus is strongly patterned in the transverse plane (i.e., medial hypothalamus vs lateral hypothalamus), these data suggested a specific alteration of mediolateral patterning.
In horizontal sections, the lateral hypothalamus can be recog- nized by the large number of longitudinal axons that course through it, as opposed to the more compact medial hypothalamus (Fig. 7C) . By this criterion, a lateral hypothalamus seems to be mostly absent in the mutant (Fig. 7D) . By crossing our Shh-c conditional mutants with the mouse reporter line Z/AP (Lobe et al., 1999) , we labeled the neurons of Foxb1 lineage (see Materials and Methods), which are very abundant in the lateral hypothalamus ( Fig. 7E ) but were dramatically reduced in the mutant (Fig.  7F ). Specific expression of marker genes pro-melaninconcentrating hormone (Pmch) (Fig. 7G ) and hypocretin-orexin (Hcrt) (Fig. 7I ) characterizes two independent neuronal subpopulations in the lateral hypothalamus. The number of Pmch neurons was extremely reduced in the mutant (Fig. 7H ) , whereas Hcrt neurons were completely absent (Fig. 7J ) . These results (summarized in Fig. 7 K, L) show that deficiency in neural Shh results in alterations of growth and terminal differentiation of the lateral hypothalamus as well as in the lack of specific, functionally important neuronal subpopulations.
Neural Shh is required to maintain expression of the mammillary survival factor Foxb1
Dependence of Foxb1 expression on neural Shh (Fig. 8 A, B) was surprising, since Foxb1 is expressed in the Shh-deficient neural plate ( Fig. 1 I, J ) , suggesting a feedback loop between both factors. We analyzed this question on cultured explants of whole embryonic forebrain. For this purpose, we dissected the forebrains of wild-type E9.5 mouse embryos, cut them open following the ventral midline, and flattened them on Millipore membranes with the neuroepithelial side down (Fig. 8C-E) . The explants were cultured for 48 h in control media or after adding one of several reagents to modify the activity of different signaling pathways. Shh pathway inhibitor cyclopamine abolished Foxb1 expression in E9.5 explants (in 8 of 10 explants; 8 of 10) (Fig. 8 F, G) , but not in E12.5 explants (9 of 11) (Fig. 8 H, I ). Therefore, between E9.5 and E12.5, neural Shh maintains Foxb1 expression, perhaps against inhibiting influences by other factors. A powerful signaling agent, Wnt8b, specifically expressed in the MBO (Fig.  8 J-L) is able to reduce the Foxb1 MAM expression domain in zebrafish (Kim et al., 2002) . We therefore tested whether canonical Wnt signaling controls Foxb1 expression. Wnt pathway activator LiCl (Stambolic et al., 1996) decreased the Foxb1 MAM expression domain (9 of 10) (Fig. 8 M, N ) . D4476 is a casein Nkx2-1 (A, C, arrows) in the wild type marks a sulcus that can be followed up to ventral levels in wild type and mutant (D-H, J, M-R, arrows). M, N, Emx2 expression shows that the sulcus corresponds in the mutant to the point at which diencephalon and telencephalon meet (N, arrow), in close proximity to a domain of Emx2 expression (N, arrowhead). This Emx2 domain can be followed in the mutant from the DTJ (N ) to ventral levels of the hypothalamus (P, R, T ). S, Expression of Emx2 in the wild-type MBO. T, A convoluted structure expresses Emx2 in the mutant.
kinase-1 inhibitor able to block the Wnt pathway (Rena et al., 2004; Bryja et al., 2007) . In explants cultured with D4476 the Foxb1 MAM expression domain increased in size (9 of 11) ( Fig.  8O-Q) . These results suggested that the Wnt pathway, probably activated by Wnt8b, restricts the Foxb1 MAM expression domain in the neuroepithelium. In agreement, as Wnt8b expression increases in the MAM neuroepithelium during development, Foxb1 is downregulated in the neuroepithelium and upregulated in the newly born MBO neurons; by E12.5 the separation of the expression domains of both markers in the MAM was complete (Fig. 8 R, S) . These results suggest that neural Shh maintains Foxb1 MBO expression, whereas Wnt8b inhibits it in the neuroepithelium, thereby restricting Foxb1 to neurons. Our results, together with some data from the literature (see Discussion), are summarized in Figure 8T .
Discussion
By analyzing a neuroepithelium-specific Shh mutant phenotype, we elucidate the differential roles of Shh from the notochord and the neuroepithelium on hypothalamic development. We show that neural Shh is essential for the coordination of tissue growth and acquisition of AP and DV patterning in the hypothalamus and the DTJ. We demonstrate a role for neural Shh in growth and pattern coordination along the mediolateral axis of the hypothalamus as well as in the specification of lateral hypothalamic neuronal subpopulations. We further show that neural Shh differentially promotes cell proliferation in the rostral and MAM regions. In addition, neural Shh influences the maintenance of Foxb1 expression in postmitotic MBO neurons by interplay with the Wnt pathway.
Finally, since our mutant expresses Nkx2-1 in the ventral diencephalon and has two eyes, our results imply that neural Shh is dispensable for hypothalamic regional specification and eye field separation, two processes depending on Shh signaling (Chiang et al., 1996; Mathieu et al., 2002) .
Neural Shh in hypothalamic precursor expansion and neurogenesis Shh is needed early for proliferation in the diencephalon (Ishibashi and McMahon, 2002) and in particular in the caudal regions (Manning et al., 2006) , which agrees with the reduced size of the hypothalamus in our mutant already at E9.5 (Fig. 3B) . Our data indicate that this requirement is temporally restricted, and by E10.5 it has disappeared. However, we show that neural Shh has some promoting effect on proliferation in the rostral hypothalamus at E12.5, during the most active phase of hypothalamic neurogenesis (Altman and Bayer, 1986; Clancy et al., 2001) . The effect of neural Shh on the neuroepithelium at this age could be direct, since weak expression of Gli1 and Ptch1 can be detected at ventral levels of the hypothalamic neuroepithelium through E12.5 and persists at least until E14.5 (data not shown). The effect of neural Shh could also be indirect, as in the early dorsal diencephalic proliferation (Ishibashi and McMahon, 2002) .
Shh is necessary for cell viability in the diencephalic neuroepithelium at E9.0 (Ishibashi and McMahon, 2002) and in the midbrain-hindbrain junction until E10.5 (Blaess et al., 2006) . We show, however, that in the hypothalamus this effect is temporally restricted, and it has disappeared by E10.5.
Neural Shh and AP patterning in the hypothalamus
In Shh-c brains, reduced growth of the medial hypothalamus causes the hypothalamic mantle to become abnormally separated into a rostral subdivision (the three rostral hypothalamic regions) and a caudal one (the MAM). The gap that is created in this way unexpectedly confirms neural plate fate-mapping data in zebrafish showing that the presumptive MAM is indeed caudal to, but not continuous with the rest of the hypothalamus (Staudt and Houart, 2007) . This region has been considered a somewhat atypical part of the hypothalamus from the point of view of specification mechanisms (Mathieu et al., 2002) , patterning (Puelles and Rubenstein, 2003) , connectivity (Thompson and Swanson, 2003) , and function (Stackman and Taube, 1998; Vann and Aggleton, 2004; Radyushkin et al., 2005) .
In addition, the mutant MAM is extremely reduced and becomes contiguous with the thalamic eminence, altering the DV pattern of the diencephalon (see below).
Neural Shh in the PTh and EMT
It has been well documented that deficiency in neural Shh from the ZLI leads to abolition of the PTh (see citations in Introduction). Therefore, our mutant lacks a PTh, as reflected by the loss of Dlx2 (Fig. 3 E, F ) and Arx expression (supplemental Fig. 1 F, G , available at www.jneurosci.org as supplemental material). However, Lhx5, a specific marker of the EMT, is preserved in our mutant, suggesting that lack of neural Shh in this region performs a genetic dissection between the two regions [Tbr1, another specific marker of the thalamic eminence, is however lost in the mutant (supplemental Fig. 1 F, G , available at www.jneurosci.org as supplemental material)]. This reduces the size of the dorsal diencephalon and enlarges the communication between the lateral ventricles and the third ventricle.
Neural Shh coordinates AP and DV patterning in the diencephalon and the formation of the DTJ Surprisingly, the patterning defects in dorsal and ventral diencephalon compound to alter the DTJ, which in the mutant extends ventrally to reach the midline (Fig. 3O,P) . This is reminiscent of the major role played by neural Shh in the coordination of the AP and DV patterning in the midbrain-hindbrain junction (Blaess et al., 2006) . In wild-type embryos, the growth of the thalamus and hypothalamus forces the expanding medial pallium to acquire a characteristic curved shape (compare, for instance, the hippocampus of wild type and mutant in Fig. 5 L, M ) . In the Shh-c embryo, the very reduced hypothalamus (and thalamus) does not oppose resistance to the pallium, which stretches unimpeded toward the midline, particularly on the ventral side ( Fig. 5A-D) . At later stages, this fact has as an unexpected consequence the presence of part of the pallium (presumably the hippocampus) mispositioned at the caudal end of the ventral hypothalamus in the mutant.
Neural Shh in mediolateral hypothalamic patterning Mediolateral patterning of the hypothalamus involves the specification of its distinctive medial and lateral zones. Between E9.5 and E13.0 approximately, Shh is expressed as a longitudinal band in the basal plate of the ventral hypothalamus . This expression domain coincides in time (E10.3-E12.7) (Altman and Bayer, 1986) and space (Altman and Bayer, 1986; Marchand et al., 1986) , with the primordium of the lateral hypothalamus. We show that abolition of Shh expression in the hypothalamic neuroepithelium results in a very reduced lateral hypothalamus in which some of the most functionally important and characteristic neuronal subpopulations are either very reduced (Pmch neurons) or completely missing (Hcrt/orexin neurons). This indicates that neural Shh has a very important and specific role in the development of the lateral hypothalamus, possibly mediated by regulation of Dlx2, Dbx1, and Foxd1 (Fig. 3 ).
An interplay between Shh and Wnt8b regulates expression of Foxb1, a crucial regulator of caudal hypothalamus development Deficiency in neural Shh translates also in incomplete differentiation of hypothalamic nuclei. We used the MBO as model to analyze this defect, since in the mutant this nucleus expresses several specific differentiation markers (Nkx2-1, Lhx1), but fails to express others like Sim1, Otp, and Foxb1. The case of Foxb1 is particularly intriguing, since it is expressed by the neural plate (E8.5) in the Shh full mutant (Fig. 1 I, J ) but fails to be expressed at E18.5 in the Shh-c MBO (Fig. 8 A, B) . Our explant experiments show that, at E12.5, the dependence on Shh has disappeared. Since Foxb1 is still missing in the mutant MBO at E18.5, we conclude that neural Shh is necessary for maintenance of Foxb1 expression.
Incidentally, since Foxb1 is essential for the survival of the MBO neurons beyond the day of birth (Alvarez-Bolado et al., 2000) , this result reveals an unexpected requirement for neural Shh in differentiation and survival of the MAM and is in keeping with data showing a role of Shh in neuronal survival in other systems (Miao et al., 1997; Oppenheim et al., 1999) .
We also show that Wnt signaling suppresses Foxb1 expression in progenitors (neuroepithelium), and therefore it counterbalances or modulates the positive effect of Shh in Foxb1 expression maintenance. The Wnt ligand involved here could be Wnt8b, a specific marker of the MAM in all vertebrates (Cui et al., 1995; Hollyday et al., 1995; Kelly et al., 1995; Lako et al., 1998; Richardson et al., 1999; Garda et al., 2002; Houart et al., 2002) . Wnt8b downregulates Foxb1 in the MAM of zebrafish (Kim et al., 2002) , controls mammillary neurogenesis (Lee et al., 2006) , and could be a local organizer (Erter et al., 2001; Houart et al., 2002) . The interplay Shh/Wnt in Foxb1 control is presumably downstream the Nodal pathway (Strähle et al., 1996; Erter et al., 2001; Rohr et al., 2001; Houart et al., 2002; Mathieu et al., 2002) (Fig. 8T ) . In black is shown our data, and in gray, data from the literature.
